首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Jco oncology practice

缩写:

ISSN:2688-1527

e-ISSN:2688-1535

IF/分区:5.5/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引2281条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Sara P Ginzberg,Y Nancy You,Rebecca A Snyder Sara P Ginzberg
The incidence of early-onset gastrointestinal (GI) cancers, typically defined by diagnosis before age 50 years, is rapidly rising in the United States and around the world. Although the underlying drivers of this trend are incompletely unde...
Rosalyn Marar,Savannah S Liddell,Nadia Toumeh et al. Rosalyn Marar et al.
Purpose: Hematology care delivery is changing rapidly for patients, care teams, and health care institutions. This study simultaneously evaluated utilization data for synchronous/real-time patient appointments, asynchrono...
Heather N Bitar,Andrew T Leitner,William Dale et al. Heather N Bitar et al.
Purpose: As part of the Alliance of Dedicated Cancer Centers' Improving Goal-Concordant Care (IGCC) initiative, we developed and delivered virtual communication skills training (CST) series to improve the quality of serio...
Shaurya Khanna,Sean Woo,Sandra P Susanibar-Adaniya et al. Shaurya Khanna et al.
Purpose: Approximately 8% of the US population speaks primary languages other than English. Limited English proficiency (LEP) contributes to under-representation of Hispanic patients in oncology clinical trials. Although ...
George Zhang,Jadon Fann,Daniela V Castro et al. George Zhang et al.
Purpose: Clinical trials for cancer tend to be less available in regions of the United States corresponding to high socioeconomic vulnerability; however, specific patterns for renal cell carcinoma (RCC) have yet to be rep...
Samer Salem,Kainat Warraich,Shilpa Gupta Samer Salem
For decades, treatment options for locally advanced and metastatic urothelial carcinoma remained largely unchanged, with platinum-based chemotherapy serving as the only effective systemic therapy. The advent of immune checkpoint inhibitors ...